A survey about the contents and features of oncology clinical pharmacy services and self‐evaluations of the oncology pharmacists in China

• DOI: 10.1111/jcpt.13191
• Publication Date: 2020-06-27T10:34:41Z
• Authors: Yanting Wang; Yuanyuan Dai; Jun Yang; Haiyan Zhou; Zhe Chen; Guohui Li
• Keywords: Salary

What is known and objective In China, with the increased number of oncology patients use novel antitumour drugs, demand clinical pharmacy services also growing. However, current status in China was seldom reported. The purpose study to investigate contents features self-evaluations pharmacists identify related problems for further development. Methods A 55-item online questionnaire distributed oncology-related Chinese hospitals January 2019. Pharmacists answered questions on WeChat platform. Data were analysed using descriptive statistics. Results discussion respondents 166 valid questionnaires from 29 provinces (or autonomous regions or municipalities). Their average working experience 4.86 years. duration their 3.27 h/d. consist 15 types, workload each service type summarized. are not frequently participating establishing pharmacotherapy protocols, therapeutic drug monitoring pharmacogenetic/pharmacogenomic services. About 80% (81.33%) thought that other healthcare professionals knew nature work. biggest barrier career development insufficiency professional skills. most cases, accounted <30% overall performance evaluation pharmacists. Most satisfied salary. score happiness 6.27 out 10. new conclusion value being increasingly recognized, but advanced need expansion. Increasing time serving patient care, optimizing mechanisms strengthening skills possible ways provide superior This showed parts which may reference policymakers, promote international communications shed light future pharmacy.